DGKA and acute myeloid leukemia: Tan et al. otherwise exploited ritanserin to pharmacologically inhibit DGKα in acute myeloid leukemia, observing a decreased cell proliferation and increased apoptosis in vitro, as well as efficacy as anti‐cancer drug in vivo models.